NVAX
NovavaxDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
NVAX vs peer average
44/100
NVAX vs. peer average (D vs. D)
Grade spread
B 3 · C 2 · D 1 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
IMTX is the first available peer comparator.
Loose small-cap biotech optionality comp; useful for development-stage risk framing but not directly comparable to Novavax's vaccine, royalty, and partnered-platform model.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NVAX
Novavax
IMTX
Immatics
Grade
D
A
Momentum
80
19
Value
44
41
Sentiment
52
89
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs IMTX
NVAX / IMTX
Grade Position
Below peers
NVAX vs. peer average (D vs. D)
44/100
Momentum
80
NVAXValue
44
NVAXSentiment
52
IMTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NVAX
IMTX is the first peer returned for this comparison set.